​In this week's edition...
 
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders.  Click here to view.
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— Tune in Tomorrow! Advancing Health Equity Through Community-Engaged Research. Click here for additional details and to watch webinar.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— PIPC Submits Feedback on ICER Assessment of ATTR-CM Treatments. Click here to read the letter.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— ICHOM Looking for Patient Partners! See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Chairman Tony Coelho's Statement on Final Passage of H.R. 485. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— Medicare Drug Price Negotiation Program: CMS Announced Prices of First 10 Drugs. See details below.  
— PIPC Submits Feedback on ICER Assessment of ATTR-CM Treatments. Click here to read the letter.
— PIPC Submits Comments on 'Cures 2.0.' RFI. See details below. 
— PCORI Annual Meeting October 22-23, 2024. See details below.
— NIH Lecture: Advancing Health Equity Through Community-Engaged Research. Click here for additional details and to watch webinar.
— FDA’s CBER Hosting Patient Listening Session on Gene Therapy, September 20. See details below.
— PIPC Submits Comments on Medicare Drug Price Negotiation Implementation Guidance. See details below.
— Due Friday! AAAS Seeks Nominations for Working Group on Disability Inclusion and Anti-Ableism. See details below.
— ICHOM Looking for Patient Partners! See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Chairman Tony Coelho's Statement on Final Passage of H.R. 485. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.

In this week's edition...
 
— PIPC Submits Comments on Medicare Drug Price Negotiation Implementation Guidance. See details below.
— AAAS Seeks Nominations for Working Group on Disability Inclusion and Anti-Ableism. See details below.
— Due Thursday! FDA Seeks Applications For Patient Engagement Collaborative. Click here for additional details and to apply.
— ICHOM Looking for Patient Partners! See details below.
— PCORI Engagement Awards Now Open! Click here to learn more. 
— Request for Information: Strategies for Maximizing Public Engagement in NIH Supported Clinical Research. Click here for more details and to submit a comment.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— PCORI Annual Meeting October 22-23, 2024. See details below.
— Chairman Tony Coelho's Statement on Final Passage of H.R. 485. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.